Skip to main content

TPCO Holding Corp. (GRAMF)

OTC Markets (US) Healthcare Drug Manufacturers - Specialty & GenericView data quality →
41.9Fair

ValueMarkers Composite Index

Top 7%#41,356 of 44,707

DCF data not available

Piotroski
3/9
Weak
Beneish
-4.74
Low Risk
Altman
-4.74
Distress
DCF Value
-
N/A
ROIC
-42.8%
Low
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

TPCO Holding Corp. (GRAMF) — VMCI valuation read

Across 120 indicators, TPCO Holding Corp. (GRAMF) lands at VMCI 42/100. The Healthcare sector median is 50, so the 8-point below-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on GRAMF in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, GRAMF trades at 27.0x earnings, 50% above the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 13.0% sits 3.0pp above the Healthcare median (10.0%). On Risk, net debt to EBITDA of -1.1x leaves covenant headroom for GRAMF on the trailing balance sheet.

GRAMF fell 2.3% over the trailing 7 days, with a +6.5% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in GRAMF’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.